Hallmarks of liver cancer: Therapeutic implications.
Saved in:
| Title: | Hallmarks of liver cancer: Therapeutic implications. |
|---|---|
| Authors: | Llovet JM; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address: josep.llovet@mountsinai.org., Pinyol R; Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Affo S; Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Yarchoan M; Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Gores GJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Lowe SW; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sia D; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Villanueva A; Division of Gastroenterology and Hepatology, Perlmutter Cancer Center, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA. |
| Source: | Cell [Cell] 2026 Apr 16; Vol. 189 (8), pp. 2490-2514. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41997132 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hallmarks of liver cancer: Therapeutic implications. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Llovet+JM%22">Llovet JM</searchLink>; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address: josep.llovet@mountsinai.org.<br /><searchLink fieldCode="AU" term="%22Pinyol+R%22">Pinyol R</searchLink>; Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Affo+S%22">Affo S</searchLink>; Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yarchoan+M%22">Yarchoan M</searchLink>; Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gores+GJ%22">Gores GJ</searchLink>; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lowe+SW%22">Lowe SW</searchLink>; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.<br /><searchLink fieldCode="AU" term="%22Sia+D%22">Sia D</searchLink>; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Villanueva+A%22">Villanueva A</searchLink>; Division of Gastroenterology and Hepatology, Perlmutter Cancer Center, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413066%22">Cell</searchLink> [Cell] 2026 Apr 16; Vol. 189 (8), pp. 2490-2514. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413066 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200928674%22">00928674 </searchLink><i>NLM ISO Abbreviation: </i>Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41997132 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cell.2026.03.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2490 Titles: – TitleFull: Hallmarks of liver cancer: Therapeutic implications. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Llovet JM – PersonEntity: Name: NameFull: Pinyol R – PersonEntity: Name: NameFull: Affo S – PersonEntity: Name: NameFull: Yarchoan M – PersonEntity: Name: NameFull: Gores GJ – PersonEntity: Name: NameFull: Kelley RK – PersonEntity: Name: NameFull: Lowe SW – PersonEntity: Name: NameFull: Sia D – PersonEntity: Name: NameFull: Villanueva A IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 04 Text: 2026 Apr 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-4172 Numbering: – Type: volume Value: 189 – Type: issue Value: 8 Titles: – TitleFull: Cell Type: main |
| ResultId | 1 |